The School of Medicine is home to an internationally renowned center for multidisciplinary research of neurofibromatosis and comprehensive care of patients affected by it. The university’s Neurofibromatosis Center will host a symposium May 16 that will bring together patients, their family members and researchers to discuss the latest insight into the diagnosis and treatment of NF.
The causes of learning problems associated with an inherited brain tumor disorder are much more complex than scientists had anticipated, researchers at Washington University School of Medicine in St. Louis report.
Insights from a genetic condition that causes brain cancer are helping scientists better understand the most common type of brain tumor in children.
Stem cells that come from a specific part of the developing brain help fuel the growth of brain tumors caused by an inherited condition, researchers, including David H. Gutmann, MD, PhD, at Washington University School of Medicine in St. Louis report.
David H. Gutmann, MD, PhD, a neurofibromatosis expert at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, has received the 2012 Friedrich von Recklinghausen Award.
The Washington University Neurofibromatosis (NF) Center at will host its first research symposium May 4. The event will focus on clinical and basic science research on neurofibromatosis 1, an inherited condition that increases risk of brain tumors in children and adults.
Nerve cells in the body and brain react in opposite ways to the loss of a protein linked to a childhood tumor syndrome, researchers at Washington University School of Medicine in St. Louis have found. The finding could be important to efforts to preserve the vision of patients with neurofibromatosis 1, a genetic condition that increases risk of benign and malignant brain tumors.